Biomedicines manufacturing facility

The facility

BioCork is Johnson & Johnson Innovative Medicine’s state-of-the-art facility producing immunology and oncology treatments. PM Group has supported the design and build of the 20,000+ sqm campus in Ireland since 2005.

About BioCork3.2

The latest project, BioCork3.2, is a 2,000 sq.m expansion. It facilitates multi-product manufacturing with increased capacity and a ‘Fed Batch’ process. This was the third expansion project at the BioCork site and was carried out alongside a live production environment.

Digital innovation enabling superior collaboration and safety

New technologies facilitated real-time, daily collaboration during the BioCork projects delivery:

• Virtual Reality: teams used virtual reality for an initial collaborative review process, enabling timely decision-making and avoiding costly rework, which kept the project schedule on track.
• 3D BIM Modelling: design and construction teams used 3D BIM Modelling to understand the installation sequence and coordination steps in detail throughout the project.
• Drone Footage: weekly interactive planning sessions incorporated drone footage to highlight work areas, enhancing visual oversight and project progression.
• Interactive Whiteboards: these allowed session leaders to email all attendees directly from the screen during meetings, streamlining communication.
• 360-Degree Internal Cameras: these cameras provided visual oversight of the project progression and helped identify inefficiencies.

Leading with sustainability

All the BioCork facilities have been designed and constructed with sustainability as a guiding principal. The latest project, BioCork 3.2 has achieved the LEED BD+C New Construction v4 Silver Award​.

Key sustainable metrics:

• 30%     Building & Process Energy Savings​
• 10%     Renewable Energy​ Contribution
• 63%     Water Savings​
• 98%     Construction Waste Recycled

Services

PM Group has been involved on all three major development projects at this c.40 hectare site from its original establishment in 2005 as a greenfield facility to produces monoclonal antibody products. Located in Ringaskiddy Co. Cork, the facility incorporates perfusion cell culture and purification processes.

Our scope has included site evaluation, master-planning and permitting, architecture and engineering design, procurement, construction management support, commissioning/qualification/validation and LEED AP consulting services.

Previous Awards
The earlier 19,000 sqm expansion project (BioCork 2) was recognised with ENR and CURT awards in 2020, and was Overall Winner and Project Execution Winner in the ISPE Facility of The Year Awards, 2021.